BOMBSHELL: Dr. Clare Craig Exposes How Pfizer Twisted Their Clinical Trial Data for Young Children

STORY AT-A-GLANCE

• The trial recruited 4,526 children aged six months to four years old. 3,000 of these children did not make it to the end of the trial. Why was there this drop off?
• There were six children aged two to four who had severe covid in the vaccine group but only one in the placebo group. So on that basis, the likelihood that this vaccine is actually causing severe covid is higher than the likelihood that it isn’t.
• The only child who was hospitalized in the trial for a fever and a seizure was vaccinated.
• In the three week period, after the first vaccine dose, thirty-four of the vaccinated children got covid and only thirteen in the placebo group which worked out as a 30% increased chance of catching covid in that three week period if you were vaccinated.
• They ignored that data and then there was an eight week gap between the second dose and the third dose where again, children were getting plenty of covid in the vaccine arm. They ignored that data.
• There was then several weeks after the third dose which they also ignored, which meant that in the end they had ignored 97% of the covid that occurred during the trial and they compared three children in the vaccine arm who had covid with seven in the placebo arm and they said that this showed the vaccine was effective.
• The children who would have been placebo, the control group, were followed up for an average of six weeks and then unblinded and given the vaccine. That’s your safety control gone forever.
• Emergency Use Authorization is meant for a situation where there’s a risk of serious injury or death. Children under five are not at risk of serious injury or death from covid.

 

Transcript:

I’m Dr. Clare Craig, I’m a Diagnostic Pathologist, and I am co-chair of the HART Group, and I want to take you through the evidence that Pfizer just presented to the FDA on the six month to four year old children.

There’s an awful lot about this trial that has shocked me and I will think will shock you too. The trial recruited 4,526 children aged six months to four years old. 3,000 of these children did not make it to the end of the trial.

That is a huge number, two thirds of them. Why was there this drop off? That needs to be answered, and without an answer to that, on that basis alone, this trial should be deemed null and void.

So what did the trial show?

Well, they defined severe covid as children who had a slightly raised heart rate or a few more breaths per minute. There were six children aged two to four who had severe covid in the vaccine group but only one in the placebo group.

So on that basis, the likelihood that this vaccine is actually causing severe covid is higher than the likelihood that it isn’t.

There was actually one child who was hospitalized in this trial. They had a fever and a seizure. They had been vaccinated.

So now let’s turn to what they defined as any covid and what they did was to utterly twist the data. They vaccinated the children and they waited three weeks after the first dose before the second dose.

In that three week period, thirty-four of the vaccinated children got covid and only thirteen in the placebo group which worked out as a 30% increased chance of catching covid in that three week period if you were vaccinated.

So they ignored that data and then there was an eight week gap between the second dose and the third dose where again, children were getting plenty of covid in the vaccine arm.

So they ignored that data. There was then several weeks after the third dose which they also ignored, which meant that in the end they had ignored 97% of the covid that occurred during the trial and they just looked at tiny numbers.

In the end they were comparing three children in the vaccine arm who had covid with seven in the placebo arm and they said that this showed the vaccine was effective.

So they measured how many of these children actually managed to catch covid twice in the two month follow-up period and there were twelve children who had covid twice and all but one of them were vaccinated, mostly with three doses.

So you have to wonder what on earth they’re thinking when the claim of reduction in covid was only four children and here we have twelve children who got covid twice — eleven of them vaccinated.

So let’s just recap. They recruited 4500 children, 3000 of them dropped out, and in the end they are claiming this vaccine works on the basis of three covid cases versus seven, a difference of four children only, and all of this on a backdrop of a disease which doesn’t affect children and with no long-term safety data.

You have to ask how an ethics committee could have approved this trial in babies. Babies are not at risk from covid and now we have Pfizer who are presenting this as evidence to the FDA in order to apply for an Emergency Use Authorization.

Emergency Use Authorization is meant for a situation where there’s a risk of serious injury or death. Now, children under five are not at risk of serious injury or death from covid. In fact, in their own trial, they had to make up other ways of measuring the problem because there was no serious injury or death.

Now, originally these products were sold as actually also reducing transmission. Now, it would be completely unethical to use young children as a human shield but we now know that they don’t reduce transmission.

The WHO have stopped claiming that they reduce transmission so that argument doesn’t apply either.

Now, if we turn to safety, what they did is they followed up patients for six weeks before unblinding them and vaccinating them. So the children who would have been placebo, the control group, were followed up for an average of six weeks and then given the vaccine.

So that’s your safety control gone forever. The fact that this trial existed at all is unbelievable. There are other issues in there which I haven’t highlighted but those are the key ones.

Parents should be demanding that the decision makers explain themselves.

Dr. Pierre Kory tweets this video to former head of the FDA and current Pfizer board member Dr. Scott Gottlieb: